Please login to the form below

Not currently logged in
Email:
Password:

EACCME

This page shows the latest EACCME news and features for those working in and with pharma, biotech and healthcare.

EFPIA: Disclose payments or face legislation

EFPIA: Disclose payments or face legislation

Her comments were backed by Edwin Borman, chair of the UEMS-EACCME – the accreditation council for CME in the EU.

Latest news

  • CME faces change

    CME accreditation bodies. The European Accreditation Council for Continuing Medical Education (EACCME) – run by the European Union of Medical Specialists (UEMS) – was the initial driving force. ... Revised standards. UEMS-EACCME is expected to

  • Navigating the minefield

    In preparation, the European Accreditation Council for Continuing Medical Education (EACCME) has recently launched pan-European accreditation for eCME.

  • E-learning programmes: an essential guide E-learning programmes: an essential guide

    In Europe, the Union Européenne des Médicins Spécialistes (UEMS) is responsible for the European Accreditation Council for Continuing Medical Education (EACCME), and provides clear guidelines on course development.

  • Mutual benefit

    The review processes at the accrediting bodies, such as the Royal Colleges in the UK, or the European Accreditation Council for CME (EACCME) in Europe, are thorough.

  • Raising the bar

    European 'rules' are taking shape and even converging. The accreditation arm of the European Union of Medical Specialists, the European Accreditation Council for CME (UEMS-EACCME) is driving some new quality ... Even the NAAs and ESABs that are not part

More from news
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...